세계의 전립선 비대증 수술 시장 : 시장 규모, 점유율, 동향, 산업 분석 : 유형별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, End User, and Region - Market Forecast, 2025-2034

US $ 4,250 ￦ 5,887,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250 ￦ 7,272,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250 ￦ 8,658,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 전립선 비대증 수술 시장 규모는 2034년까지 211억 9,000만 달러에 달할 것으로 예측됩니다.

전립선 비대증(BPH) 수술 시장은 빈뇨, 요폐, 방광염 등의 증상을 유발하는 전립선 비대증 병태생리를 치료하는 데 초점을 맞추고 있으며, BPH 수술은 약물 치료와 같은 보존적 요법으로 증상을 완화할 수 없을 때 필요합니다. 전립선비대증 시장은 특히 전립선비대증에 취약한 고령 남성의 전립선비대증 발병률 증가로 인해 눈에 띄는 성장세를 보이고 있습니다. 레이저 치료, 경요도적 전립선 절제술(TURP), 전립선 동맥 색전술(PAE)과 같은 최소침습적 수술에 대한 수요 증가가 전립선 비대증 수술 시장 확대에 크게 기여하고 있습니다.

회복 시간 단축, 합병증 감소, 입원 기간 단축 등 환자 예후를 개선하는 수술 기술의 개발은 시장 성장의 주요 촉진요인 중 하나입니다. 또한, BPH에 대한 인식과 진단의 향상, 의료 접근성 및 상환 정책의 강화가 시장 수요를 촉진하고 있습니다. 로봇 보조 수술의 도입과 레이저 수술의 채택 확대는 치료 환경을 변화시켜 환자에게 더 많은 선택권을 제공하고 전체 전립선 비대증 수술 시장의 성장을 가속하고 있습니다.

시장 역학에는 외래 환자들의 수술 선호도 증가가 포함되며, 이는 수술 기법의 혁신을 촉진하고 있습니다. 또한, 여러 지역에서 가처분 소득이 증가함에 따라 고급 치료에 대한 접근성이 확대되고 있습니다. 고령화와 환자 중심 솔루션에 대한 관심이 증가함에 따라 시장 확대의 기회가 많습니다. 시장에서는 연구 개발 활동도 활발해져 치료 옵션을 더욱 최적화하고 가치 기반 의료를 촉진할 것으로 예측됩니다. 그 결과, 시장은 계속 진화하여 의료 산업 이해관계자들에게 유망한 기회를 제공할 것으로 예측됩니다.

전립선 비대증 수술 시장 보고서의 하이라이트

유형별로는 정밀성, 최소 침습성, 짧은 회복 시간으로 인해 레이저 수술 부문이 2024년 큰 시장 점유율을 차지했습니다.

최종 사용자별로는 편의성과 비용 효율적인 치료 옵션에 대한 환자 선호도가 높아짐에 따라 재택치료 부문이 2024년 가장 큰 시장 점유율을 차지했습니다.

2024년 북미는 전립선 비대증의 높은 유병률과 선진화된 의료 인프라로 인해 가장 큰 시장 점유율을 차지했습니다.

아시아태평양의 전립선 비대증 치료 시장은 의료 접근성 향상과 노인 인구 증가로 인해 예측 기간 동안 가장 빠르게 성장할 것으로 예측됩니다.

세계 주요 시장 기업으로는 Allium; Alembic Pharmaceuticals Limited; Asahi Kasei Corporation; Asclepion Laser Technologies GmbH; Boston Scientific Corporation; Coloplast Group; Cook Medical; IPG Photonics Corporation; Karl Storz Se & Co. KG; Medifocus, Inc.; Olympus Corporation; PNN Medical A/S; ProstaLund Ab; PROCEPT BioRobotics Corporation; Quanta System; Richard Wolf GmbH; SRS Medical; Teleflex Incorporated; Urologix, LLC. 등이 있습니다.

이 보고서는 세계 전립선 비대증 수술 시장에 대해 조사했으며, 현재 시장 역학에 대한 상세한 고찰과 향후 시장 성장에 대한 분석을 제공합니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 전립선 비대증 수술 시장 인사이트

• 시장 현황
• 전립선 비대증 수술 시장 역학
  • 성장 촉진요인과 기회
  • 성장 억제요인과 과제
• PESTEL 분석
• 전립선 비대증 수술 시장 용도 동향
• 밸류체인 분석

제5장 세계의 전립선 비대증 수술 시장 : 유형별

• 주요 조사 결과
• 서론
• 경요도적 전립선 절제술(TURP)
• 레이저 수술
• Urolift 수술
• Rezum 수술
• 로봇 지원 워터젯 절제
• 전립선 스텐트
• 경요도적 마이크로파 온열 요법(TUMT)
• 전립선 경요도 니들 절제(TUNA)
• 전립선 동맥색전술(PAE)
• 기타 수술

제6장 세계의 전립선 비대증 수술 시장 : 최종사용자별

• 주요 조사 결과
• 서론
• 병원
• 외래수술센터(ASC) 및 진료소
• 재택치료

제7장 세계의 전립선 비대증 수술 시장 : 지역별

• 주요 조사 결과
• 서론
  • 전립선 비대증 수술 시장 분석 : 지역별(2020년-2034년)
• 북미
  • 북미 : 유형별(2020년-2034년)
  • 북미 : 최종사용자별(2020년-2034년)
  • 미국
  • 캐나다
• 유럽
  • 유럽 : 유형별(2020년-2034년)
  • 유럽 : 최종사용자별(2020년-2034년)
  • 영국
  • 프랑스
  • 독일
  • 이탈리아
  • 스페인
  • 네덜란드
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 아시아태평양 : 유형별(2020년-2034년)
  • 아시아태평양 : 최종사용자별(2020년-2034년)
  • 중국
  • 인도
  • 말레이시아
  • 일본
  • 인도네시아
  • 한국
  • 호주
  • 기타 아시아태평양
• 중동 및 아프리카
  • 중동 및 아프리카 : 유형별(2020년-2034년)
  • 중동 및 아프리카 : 최종사용자별(2020년-2034년)
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 남아프리카공화국
  • 기타 중동 및 아프리카
• 라틴아메리카
  • 라틴아메리카 : 유형별(2020년-2034년)
  • 라틴아메리카 : 최종사용자별(2020년-2034년)
  • 멕시코
  • 브라질
  • 아르헨티나
  • 기타 라틴아메리카

제8장 경쟁 구도

• 확장 및 인수 분석
  • 확대
  • 인수
• 파트너십/협업/합의/공개

제9장 기업 개요

• Allium
• Alembic Pharmaceuticals Limited
• Asahi Kasei Corporation
• Asclepion Laser Technologies GmbH
• Boston Scientific Corporation
• Coloplast Group
• Cook Medical
• IPG Photonics Corporation
• Karl Storz Se & Co. KG
• Medifocus, Inc.
• Olympus Corporation
• PNN Medical A/S
• ProstaLund Ab
• PROCEPT BioRobotics Corporatio
• Quanta System
• Richard Wolf GmbH
• SRS Medical
• Teleflex Incorporated
• Urologix, LLC

LSH

영문 목차

영문목차

The global benign prostatic hyperplasia surgical treatment market size is expected to reach USD 21.19 billion by 2034, according to a new study by Polaris Market Research. The report "Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, End User (Hospitals, Ambulatory Surgery Centers and Clinics, and Homecare Settings), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The benign prostatic hyperplasia (BPH) surgical treatment market focuses on addressing the medical condition of an enlarged prostate, which often leads to symptoms such as frequent urination, urinary retention, and bladder infections. Surgical treatments for BPH are necessary when conservative therapies like medications fail to alleviate symptoms. The market has seen notable growth, driven by an increasing incidence of BPH, especially among the aging male population, who are more susceptible to prostate enlargement. The rising demand for minimally invasive procedures, such as laser-based therapies, transurethral resection of the prostate (TURP), and prostate artery embolization (PAE), is significantly contributing to the benign prostatic hyperplasia surgical treatment market expansion.

Advancements in surgical technology, which offer improved patient outcomes with shorter recovery times, reduced complications, and minimal hospital stays, is one of the key factors fueling market development. Moreover, rising awareness and diagnosis of BPH, coupled with increased healthcare access and reimbursement policies, have propelled market demand. The introduction of robotic-assisted surgeries and the growing adoption of laser surgeries are transforming the treatment landscape, providing patients with more options and driving the overall benign prostatic hyperplasia surgical treatment market growth.

The market dynamics also include a growing preference for outpatient procedures, which has spurred innovation in surgical techniques. Additionally, rising disposable income in several regions is enabling greater access to advanced treatments. The market holds considerable opportunity for expansion as the population continues to age, with an increasing focus on patient-centric solutions. The market is also poised to witness more research and development efforts, further optimizing treatment options and promoting value-based care. Consequently, the market is expected to continue evolving, presenting promising opportunities for stakeholders involved in the healthcare industry.

Benign Prostatic Hyperplasia Surgical Treatment Market Report Highlights

In terms of type, the laser surgeries segment accounted for a significant market share in 2024 due to their precision, minimal invasiveness, and shorter recovery time.

Based on end user, the homecare settings segment accounted for the largest market share in 2024 due to growing patient preference for convenience and cost-effective treatment options.

In 2024, North America accounted for the largest market share due to the high prevalence of BPH and advanced healthcare infrastructure.

The Asia Pacific benign prostatic hyperplasia surgical treatment market is expected to witness the fastest growth during the forecast period due to increasing healthcare access and a rising elderly population.

Some of the global key market players are Allium; Alembic Pharmaceuticals Limited; Asahi Kasei Corporation; Asclepion Laser Technologies GmbH; Boston Scientific Corporation; Coloplast Group; Cook Medical; IPG Photonics Corporation; Karl Storz Se & Co. KG; Medifocus, Inc.; Olympus Corporation; PNN Medical A/S; ProstaLund Ab; PROCEPT BioRobotics Corporation; Quanta System; Richard Wolf GmbH; SRS Medical; Teleflex Incorporated; and Urologix, LLC.

Polaris Market Research has segmented the benign prostatic hyperplasia surgical treatment market report on the basis of type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

• Transurethral Resection of the Prostate (TURP)
• Laser Surgeries
• Urolift Procedures
• Rezum Procedures
• Robot-Assisted Waterjet Ablation
• Prostatic Stents
• Transurethral Microwave Thermotherapy (TUMT)
• Transurethral Needle Ablation of the Prostate (TUNA)
• Prostatic Arterial Embolization (PAE)
• Other Procedures

By End User Outlook (Revenue, USD Billion, 2020-2034)

• Hospitals
• Ambulatory Surgery Centers and Clinics
• Homecare Settings

By Regional Outlook (Revenue, USD Billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa
• Latin America
• Mexico
• Brazil
• Argentina
• Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Benign Prostatic Hyperplasia Surgical Treatment Market Insights

• 4.1. Benign Prostatic Hyperplasia Surgical Treatment Market - Market Snapshot
• 4.2. Benign Prostatic Hyperplasia Surgical Treatment Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Adoption of Minimally Invasive Procedures
    • 4.2.1.2. Expanding Geriatric Population
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Costs of Surgery
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Benign Prostatic Hyperplasia Surgical Treatment Market Application Trends
• 4.6. Value Chain Analysis

5. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
• 5.3. Transurethral Resection of the Prostate (TURP)
  • 5.3.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Resection of the Prostate (TURP), by Region, 2020-2034 (USD Billion)
• 5.4. Laser Surgeries
  • 5.4.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Laser Surgeries, by Region, 2020-2034 (USD Billion)
• 5.5. Urolift Procedures
  • 5.5.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Urolift Procedures, by Region, 2020-2034 (USD Billion)
• 5.6. Rezum Procedures
  • 5.6.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Rezum Procedures, by Region, 2020-2034 (USD Billion)
• 5.7. Robot-Assisted Waterjet Ablation
  • 5.7.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, Robot-Assisted Waterjet Ablation, by Region, 2020-2034 (USD Billion)
• 5.8. Prostatic Stents
  • 5.8.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Stents, by Region, 2020-2034 (USD Billion)
• 5.9. Transurethral Microwave Thermotherapy (TUMT)
  • 5.9.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Microwave Thermotherapy (TUMT), by Region, 2020-2034 (USD Billion)
• 5.10. Transurethral Needle Ablation of the Prostate (TUNA)
  • 5.10.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Needle Ablation of the Prostate (TUNA), by Region, 2020-2034 (USD Billion)
• 5.11. Prostatic Arterial Embolization (PAE)
  • 5.11.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Arterial Embolization (PAE), by Region, 2020-2034 (USD Billion)
• 5.12. Other Procedures
  • 5.12.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Other Procedures, by Region, 2020-2034 (USD Billion)

6. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
• 6.3. Hospitals
  • 6.3.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 6.4. Ambulatory Surgery Centers and Clinics
  • 6.4.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Ambulatory Surgery Centers and Clinics, by Region, 2020-2034 (USD Billion)
• 6.5. Homecare Settings
  • 6.5.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)

7. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Geography

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Benign Prostatic Hyperplasia Surgical Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
• 7.3. Benign Prostatic Hyperplasia Surgical Treatment Market - North America
  • 7.3.1. North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • 7.3.2. North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.3.3. Benign Prostatic Hyperplasia Surgical Treatment Market - U.S.
    • 7.3.3.1. U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.3.3.2. U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.3.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Canada
    • 7.3.4.1. Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.3.4.2. Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
• 7.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Europe
  • 7.4.1. Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • 7.4.2. Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4.3. Benign Prostatic Hyperplasia Surgical Treatment Market - UK
    • 7.4.3.1. UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.3.2. UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4.4. Benign Prostatic Hyperplasia Surgical Treatment Market - France
    • 7.4.4.1. France: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.4.2. France: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Germany
    • 7.4.5.1. Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.5.2. Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Italy
    • 7.4.6.1. Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.6.2. Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Spain
    • 7.4.7.1. Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.7.2. Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4.8. Benign Prostatic Hyperplasia Surgical Treatment Market - Netherlands
    • 7.4.8.1. Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.8.2. Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4.9. Benign Prostatic Hyperplasia Surgical Treatment Market - Russia
    • 7.4.9.1. Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.9.2. Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4.10. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Europe
    • 7.4.10.1. Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.10.2. Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
• 7.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Asia Pacific
  • 7.5.1. Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • 7.5.2. Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5.3. Benign Prostatic Hyperplasia Surgical Treatment Market - China
    • 7.5.3.1. China: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.3.2. China: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5.4. Benign Prostatic Hyperplasia Surgical Treatment Market - India
    • 7.5.4.1. India: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.4.2. India: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Malaysia
    • 7.5.5.1. Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.5.2. Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Japan
    • 7.5.6.1. Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.6.2. Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Indonesia
    • 7.5.7.1. Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.7.2. Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5.8. Benign Prostatic Hyperplasia Surgical Treatment Market - South Korea
    • 7.5.8.1. South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.8.2. South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5.9. Benign Prostatic Hyperplasia Surgical Treatment Market - Australia
    • 7.5.9.1. Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.9.2. Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5.10. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Asia Pacific
    • 7.5.10.1. Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.10.2. Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
• 7.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • 7.6.2. Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.6.3. Benign Prostatic Hyperplasia Surgical Treatment Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.6.3.2. Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.6.4. Benign Prostatic Hyperplasia Surgical Treatment Market - UAE
    • 7.6.4.1. UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.6.4.2. UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.6.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Israel
    • 7.6.5.1. Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.6.5.2. Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.6.6. Benign Prostatic Hyperplasia Surgical Treatment Market - South Africa
    • 7.6.6.1. South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.6.6.2. South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.6.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Middle East & Africa
    • 7.6.7.1. Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.6.7.2. Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
• 7.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Latin America
  • 7.7.1. Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • 7.7.2. Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.7.3. Benign Prostatic Hyperplasia Surgical Treatment Market - Mexico
    • 7.7.3.1. Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.7.3.2. Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.7.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Brazil
    • 7.7.4.1. Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.7.4.2. Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.7.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Argentina
    • 7.7.5.1. Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.7.5.2. Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.7.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Latin America
    • 7.7.6.1. Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.7.6.2. Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Allium
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Alembic Pharmaceuticals Limited
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. Asahi Kasei Corporation
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Asclepion Laser Technologies GmbH
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Boston Scientific Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. Coloplast Group
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. Cook Medical
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. IPG Photonics Corporation
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. Karl Storz Se & Co. KG
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development
• 9.10. Medifocus, Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Development
• 9.11. Olympus Corporation
  • 9.11.1. Company Overview
  • 9.11.2. Financial Performance
  • 9.11.3. Product Benchmarking
  • 9.11.4. Recent Development
• 9.12. PNN Medical A/S
  • 9.12.1. Company Overview
  • 9.12.2. Financial Performance
  • 9.12.3. Product Benchmarking
  • 9.12.4. Recent Development
• 9.13. ProstaLund Ab
  • 9.13.1. Company Overview
  • 9.13.2. Financial Performance
  • 9.13.3. Product Benchmarking
  • 9.13.4. Recent Development
• 9.14. PROCEPT BioRobotics Corporatio
  • 9.14.1. Company Overview
  • 9.14.2. Financial Performance
  • 9.14.3. Product Benchmarking
  • 9.14.4. Recent Development
• 9.15. Quanta System
  • 9.15.1. Company Overview
  • 9.15.2. Financial Performance
  • 9.15.3. Product Benchmarking
  • 9.15.4. Recent Development
• 9.16. Richard Wolf GmbH
  • 9.16.1. Company Overview
  • 9.16.2. Financial Performance
  • 9.16.3. Product Benchmarking
  • 9.16.4. Recent Development
• 9.17. SRS Medical
  • 9.17.1. Company Overview
  • 9.17.2. Financial Performance
  • 9.17.3. Product Benchmarking
  • 9.17.4. Recent Development
• 9.18. Teleflex Incorporated
  • 9.18.1. Company Overview
  • 9.18.2. Financial Performance
  • 9.18.3. Product Benchmarking
  • 9.18.4. Recent Development
• 9.19. Urologix, LLC
  • 9.19.1. Company Overview
  • 9.19.2. Financial Performance
  • 9.19.3. Product Benchmarking
  • 9.19.4. Recent Development

관련자료